FDA’s requirement for truthful, balanced risk and benefit information applies to drugmakers, leaving a loophole for both ...

Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

Members of the NIH’s recently reconstituted scientific management review board had strong reactions to congressional ...

Part 3 of this series for Global Biosimilars Week, penned by Dracey Poore, director of biosimilars at Cardinal Health, ...

GE HealthCare Technologies GEHC recently announced the receipt of FDA clearance for its SIGNA MAGNUS, a 3.0T high-performance ...

Good morning and welcome to ImmuCell Corporation Reports Third Quarter September 30, 2024, Unaudited Financial Results Conference Call. All participants will be in listen-only mode. After today’s ...

Americans are fed up with the price of food, and many are looking to President-elect Donald Trump to lower their grocery ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

The pulse oximeter, a device that measures the degree to which red blood cells are saturated with oxygen, is one of healthcare’s most fundamental tools.

People suffering from major depressive disorder (MDD) and treatment-resistant depression (TRD) often face challenging ...